1 Oct 2019 11:25
Director/PDMR Shareholding
Oxford, UK - 1 October 2019: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces that on 30 September 2019, Jonathan Emms, Chief Operating Officer of Circassia, purchased 300,000 Ordinary Shares on the London Stock Exchange at a price of 16.5 pence per share.
Contacts
Circassia Steve Harris, Chief Executive Officer Julien Cotta, Chief Financial Officer Rob Budge, Corporate Communications
| Tel: +44 (0)1865 405560
|
Peel Hunt (Nominated Adviser and Joint Broker) James Steel / Dr Christopher Golden
| Tel: +44 (0) 20 7418 8900
|
finnCap (Joint Broker) Geoff Nash / Alice Lane
| Tel: +44 (0) 20 7220 0500 |
Numis Securities (Joint Broker) James Black / Freddie Barnfield
| Tel: +44 (0) 20 7260 1000
|
FTI Consulting Simon Conway / Ciara Martin | Tel: +44 (0) 20 3727 1000
|
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a. | Name | Jonathan Emms | ||||
2. | Reason for the notification | |||||
a. | Position/status | Chief Operating Officer | ||||
b. | Initial notification /Amendment
| Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a. | Name | Circassia Pharmaceuticals plc | ||||
b. | LEI | 2138006YAT138TOGA556 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary Shares of 0.08p each
GB00BJVD3B28 | ||||
b. | Nature of the transaction | Purchase of Ordinary Shares
| ||||
c. | Price(s) and volume(s) |
| ||||
d. | Aggregated information ·; Aggregated volume ·; Price
|
n/a
| ||||
e. | Date of the transaction | 2019-09-30 | ||||
f. | Place of the transaction | London Stock Exchange, AIM
| ||||